Better Buy: Emerson Electric vs. 3M

NYSE: EMR | Emerson Electric Co. News, Ratings, and Charts

EMR – Favorable policies and increasing automated machinery and equipment adoption should drive the industrial industry’s growth. Therefore, prominent players in this space, Emerson Electric (EMR) and 3M (MMM), should benefit. But which of these stocks is a better buy now? Read more to find out.

Continued adoption of advanced technologies, favorable government policies, and an increased focus on domestic production amid growing supply chain constraints worldwide should drive the growth of the industrial sector. The global industrial machinery market is expected to grow at a 3.5% CAGR from 2021 to 2027. 

Emerson Electric Co. (EMR) and 3M Company (MMM) are two prominent players in the industrial space. EMR designs and manufactures electronic and electrical equipment, software, systems, and services. It offers products for industrial, commercial, and consumer markets worldwide through its network power, process management, industrial automation, climate technologies, and commercial and residential solutions divisions. MMM operates as a diversified technology company that operates through Safety and Industrial; Transportation and Electronics; Health Care; and Consumer segments. It offers its products through e-commerce and traditional wholesalers, retailers, jobbers, distributors, and dealers.

Year-to-date, EMR has lost 7% and MMM is has dropped 17%.  Which of these stocks is a better pick now? Let’s find out.

Click here to check out our Industrial Sector Report for 2022

Latest Developments

On May 24, 2022, EMR and Toyota Australia, an Australian subsidiary of the Japanese car manufacturer Toyota Motor Corporation (TM), collaborated to transform part of Toyota Australia’s operations into commercial-grade hydrogen production, storage, and refueling plant. For the Toyota Australia Hydrogen Center, EMR’s advanced DeltaV distributed control system gathers data from the plant’s complex equipment, making it easier to monitor the production and storage of hydrogen gas and document and validate the sustainability of operations. Supported by the Australian Renewable Energy Agency (ARENA), EMR’s automation expertise helps Toyota Australia demonstrate the technical and economic feasibility of manufacturing hydrogen fuels, including the use of renewable solar energy. This should nurture EMR’s partnership with Toyota Australia in the long run.

On May 16, 2022, Robotics Business Review (RBR) named the 3M Finesse-It Robotic Paint Repair System a 2022 RBR50 Robotics Innovation Award Honoree. This system uses advanced vision system data and repairs paint defects on automobiles coming off the assembly line. This award reflects its growing reach in the robotics sector.

Recent Financial Results

EMR’s net sales for its fiscal 2022 second quarter ended March 31, 2022, increased 8.1% year-over-year to $4.79 billion. The company’s adjusted EBITA came in at $967 million, representing an 8.9% rise from the year-ago period. While its net earnings increased 18.8% year-over-year to $675 million, its adjusted EPS grew 20.6% to $1.29. As of March 31, 2022, the company had $6.93 billion in cash and equivalents.

For its fiscal 2022 first quarter ended March 31, 2022, MMM’s net sales declined 0.3% year-over-year to $8.83 billion. The company’s operating income came in at $1.64 billion, representing a 17.7% rise from the prior-year period. Its adjusted net income came in at $1.52 billion, down 11.8% from the year-ago period. MMM’s EPS came in at $575, indicating a 1.9% year-over-year decline. As of March 31, 2022, the company had $3.25 billion in cash and cash equivalents.

Past and Expected Financial Performance

Over the past three years, EMR’s net income and levered free cash flow have increased at CAGRs of 7.4% and 6.8%, respectively.

EMR’s EPS is expected to increase 22.9% year-over-year in fiscal 2022, ending September 30, 2022, and 8.3% in fiscal 2023. Its revenue is expected to grow 8.6% in fiscal 2022 and 6.1% in fiscal 2023. Analysts expect the company’s EPS to rise at a 10.3% rate per annum over the next five years.

Over the past three years, MMM’s net income and levered free cash flow have declined at CAGRs of 0.3% and 4.8%, respectively.

Analysts expect MMM’s EPS to grow 7.1% year-over-year in fiscal 2022, ending December 31, 2022, and 5.3% in fiscal 2023. Its revenue is expected to grow 1.5% year-over-year in fiscal 2022 and 3.3% in fiscal 2023. Analysts expect the company’s EPS to grow at a 6.6% rate per annum over the next five years.

Valuation

In terms of non-GAAP forward PEG, MMM is currently trading at 1.70x, 10.4% higher than EMR’s 1.54x. In terms of trailing-12-month Price-to-Book, EMR’s 4.73x compares with MMM’s 5.56x.

Profitability

MMM’s trailing-12-month revenue is 1.9 times EMR’s. MMM is also more profitable, with a 26.8% EBITDA margin versus EMR’s 21.8%.

Furthermore, MMM’s ROE, ROA, and ROTC of 38.9%, 10.1%, and 14.4% compare with EMR’s 29.1%, 7.9%, and 10.7%, respectively.

POWR Ratings

While EMR has an overall B grade, which translates to Buy in our proprietary POWR Ratings system, MMM has an overall C grade, equating to Neutral. The POWR Ratings are calculated by considering 118 distinct factors, each weighted to an optimal degree.

Both EMR and MMM have been graded a C for Momentum, consistent with their weak price performance. EMR has lost 6.9% year-to-date, while MMM fell 17.2%.

EMR has been graded a B in terms of Sentiment, which is in sync with expected earnings growth. EMR’s EPS is expected to grow 8.4% year-over-year to $5.09 billion for the fiscal 2022 third quarter ending June 30, 2022. MMM’s C grade for Sentiment reflects its lower revenue estimated by analysts. The consensus revenue estimate of $8.91 billion for MMM’s fiscal 2022 second quarter ending June 30, 20222, represents a 0.4% decline from the prior-year period.

Of the 94 stocks in the Industrial – Equipment industry, EMR is ranked #21. In contrast, MMM is ranked #44 of 81 stocks in the Industrial – Machinery industry.

Beyond what we have stated above, our POWR Ratings system has graded EMR and MMM for Value, Quality, Stability, and Growth. Get all EMR ratings here. Also, click here to see the additional POWR Ratings for MMM.

The Winner

Increasing demand and focus on domestic production should help EMR and MMM benefit in the coming months. However, a relatively lower valuation makes EMR a better buy here.

Our research shows that the odds of success increase if one bets on stocks with an Overall POWR Ratings of Buy or Strong Buy. Click here to access the top-rated stocks in the Industrial – Equipment industry and here for those in the Industrial – Machinery industry.


EMR shares were trading at $88.40 per share on Friday afternoon, up $1.80 (+2.08%). Year-to-date, EMR has declined -3.82%, versus a -12.30% rise in the benchmark S&P 500 index during the same period.


About the Author: Sweta Vijayan


Sweta is an investment analyst and journalist with a special interest in finding market inefficiencies. She’s passionate about educating investors, so that they may find success in the stock market. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
EMRGet RatingGet RatingGet Rating
MMMGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

Bullish or Bearish or BOTH???

The stock market (SPY) is becoming more complicated by the day. Bulls make a good case given the recent rally. But so do the bears given the clear weakness in the economy pointing to recession. Who is right? And how best to trade the market in the weeks and months ahead? 40 year investment veteran Steve Reitmeister shares his balanced views in this fresh commentary below…

:  |  News, Ratings, and Charts

3 Stocks to Get Bullish on Now

The Fed’s recent 25 bps rate hike in response to cooling inflation and Powell’s dovish comments improved investor sentiment. Amid growing optimism over the slowing interest rate hikes, we think fundamentally strong stocks Archer-Daniels-Midland (ADM), Biogen (BIIB), and MasterCraft (MCFT) are ideal additions to one’s portfolio. Read on…

:  |  News, Ratings, and Charts

1 Stock That Will Hold up No Matter the Market Conditions

Defying macro headwinds, Kellogg Company (K) delivered stable gains over the past year. Moreover, K currently pays more than 3% dividend. Also, its robust fundamentals should help the stock sustain its gains. So, this consumer staples giant should be worth holding now. Keep reading...

:  |  News, Ratings, and Charts

2 High-Flying Growth Stocks to Buy Now

As inflation continues to ease, the Fed recently raised interest rates by 25 bps, lower than its December hike of 50 bps. With the continued slowdown in rate hikes and the economy moving in the right direction, a soft landing for the economy looks increasingly possible to most analysts. Hence, it could be wise to invest in fundamentally strong growth stocks Celestica (CLS) and Universal Logistics (ULH. Read on…

:  |  News, Ratings, and Charts

1 Stock That Will Hold up No Matter the Market Conditions

Defying macro headwinds, Kellogg Company (K) delivered stable gains over the past year. Moreover, K currently pays more than 3% dividend. Also, its robust fundamentals should help the stock sustain its gains. So, this consumer staples giant should be worth holding now. Keep reading...

Read More Stories

More Emerson Electric Co. (EMR) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All EMR News